Log in to access your PharmaMiles
and download the data
| Last Updated on PharmaCompass | Virtual Booth | Country | Holder | DMF No. | Subject | Submission Date | Status | Type | GDUFA DMF Review | GDUFA Review Date | GDUFA Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 28/03/2025 | National Cancer Institute |
U.S.A |
NATIONAL INSTITUTES HEALTH NATIONAL CANCER INSTITUTE | 18615 | PSEUDOMONAS EXOTOXIN (RECOMBINANT, NLYSPE38) CONJUGATED MURINE MAB (B3) TO B3 ANTIGEN AND RITUXIMAB [CHIMERIC MOAB (C2B8) (IDEC) TO CD20] | 1993-03-22 | Inactive | II | N/A |
